Stemride International Limited (SIL) offers human Embryonic Stem Cell (hESC) lines to organizations conducting genetic, biological, and medical research. It provides training and consulting to professionals working with hESC.SIL has a bank of more than 100 lines including 20 lines with genetic or chromosomal abnormalities. The company is closely affiliated with the Reproductive Genetics Institute (RGI of Chicago, USA) – world leader in Preimplantation Genetic Diagnosis (PGD). SIL capitalizes on the great experience of the RGI in IVF, PGD, stem cell research, etc. SIL’s leading scientists and specialists work in close cooperation with RGI’s specialists and actively participate in research and development of both companies. RGI developed an original technique for the establishment of hESC lines from human embryos at the morula stage, which were shown to meet the NIH criteria. These lines are the basis of our bank. Stemride International is adhered to highest moral, ethical, and scientific principals accepted by the contemporary medicine and biology. SIL is a company devoted entirely to providing the best value hESC lines to institutions conducting research in accordance with laws and regulations set forth by their governments or/and regulatory agencies.
SIL aims to establish long-lasting relationships with its customers. It is open to strategic partnership and close cooperation with research institutions having common interests in the areas of gene therapy, diagnostics, pharmacology, etc.
Stemride International offers high quality Human Embryonic Stem Cell lines. There are more than one hundred twenty normal lines in the company’s bank and about thirty carrying genetic or chromosomal abnormalities. All hESC lines were derived from embryos donated by patients of the Reproductive Genetics Institute (RGI) who underwent the IVF treatment in the institute and its centers. The patients have been given complete and comprehensive information about the future of the embryos and the value of their contribution for science and medicine. The patients signed consent form with clear understanding that embryos, which were left in-vitro after the IVF cycle, will constitute the source of stem cells for the scientific research. The stem cell bank contains lines derived from the embryos in the morula stage and blastocysts grown on human and animal feeders.
UK
Stemride International Ltd
78 Brompton Park Crescent
London SW6 1SP
| Tel: +44 (0)20 7381 3097 |
| 44 (0)79 1985 2538 |
